Grant Funding Scoutv0.1.0

A research institute uses Grant Funding Scout to analyze NIH funding trends over the past 3 years in cancer immunotherapy. The tool identifies CAR-T and checkpoint inhibitors as rapidly growing areas, guiding the institute to allocate resources toward these hot topics and avoid declining fields.

A biotech startup uses the tool to avoid oversaturated areas like general monoclonal antibodies and pivot to emerging niches such as bispecific T-cell engagers. This strategic positioning increases their chances of securing NIH SBIR grants.

A pharmaceutical company's R&D team runs an analysis on 'Alzheimer's therapeutics' over 5 years. The output reveals a steady increase in funding for tau-targeting therapies, prompting the team to adjust their pipeline to include tau-focused approaches.

A university grants office uses the tool across multiple departments (e.g., neuroscience, genomics) to identify top-funded institutions and PIs. They use this intelligence to form collaborations with leading labs and align internal funding with high-priority areas.

A nonprofit organization dedicated to rare diseases uses Grant Funding Scout to analyze NIH funding patterns. They discover a gap in funding for specific rare cancers and decide to launch a targeted grant call to fill that void.

Offer tiered subscription plans (basic, professional, enterprise) to universities, research hospitals, and biotech firms. Basic includes quarterly trend reports, enterprise offers real-time API access and custom analytics.

Provide paid consulting engagements where the tool's output is combined with expert analysis to deliver actionable grant strategies for clients. Consulting packages include landscape reports, PI mapping, and proposal reviews.

License aggregated funding trend data and predictions to pharmaceutical companies and contract research organizations (CROs) for internal strategic planning. Data can be delivered via API or regular data dumps.